SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-007409
Filing Date
2020-02-27
Accepted
2020-02-27 16:34:29
Documents
86
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ntla-10k_20191231.htm   iXBRL 10-K 3633007
2 EX-4.4 ntla-ex44_526.htm EX-4.4 40081
3 EX-10.21 ntla-ex1021_527.htm EX-10.21 19989
4 EX-21.1 ntla-ex211_9.htm EX-21.1 3516
5 EX-23.1 ntla-ex231_6.htm EX-23.1 3906
6 EX-31.1 ntla-ex311_7.htm EX-31.1 8833
7 EX-31.2 ntla-ex312_8.htm EX-31.2 8725
8 EX-32.1 ntla-ex321_11.htm EX-32.1 7367
9 GRAPHIC gnwe0kr3ykab000002.jpg GRAPHIC 36483
10 GRAPHIC gnwe0kr3ykab000003.jpg GRAPHIC 32541
11 GRAPHIC gnwe0kr3ykab000001.jpg GRAPHIC 32541
  Complete submission text file 0001564590-20-007409.txt   12231266

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA ntla-20191231.xsd EX-101.SCH 63638
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ntla-20191231_cal.xml EX-101.CAL 56301
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ntla-20191231_def.xml EX-101.DEF 178585
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntla-20191231_lab.xml EX-101.LAB 508055
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntla-20191231_pre.xml EX-101.PRE 376237
78 EXTRACTED XBRL INSTANCE DOCUMENT ntla-10k_20191231_htm.xml XML 2464009
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37766 | Film No.: 20662743
SIC: 2835 In Vitro & In Vivo Diagnostic Substances